MHC expression is controlled by interferon gamma (IFNγ), which is primarily produced by cells of the immune system and binds to the heterodimeric receptor complex, IFNGR1/IFNGR2, on tumor cells, activating the JAK1/2-STAT1 signaling cascade [32]. This evidence concerns the gene HLA-C and neoplasm.